The most effective way to get a GLP-1 covered is to confirm that your plan covers the medication for your diagnosis, then have your prescriber submit a complete prior-authorization request that follows the plan's criteria.

For eligible Medicare Part D beneficiaries, the temporary Medicare GLP-1 Bridge is scheduled to begin on July 1, 2026, with a $50 monthly copayment. Most other patients will need to work through their plan's formulary and prior-authorization rules.

Your request will usually need to include your diagnosis, BMI or blood-sugar history, related health conditions, previous treatments, and the reason the medication is medically appropriate.

If your plan excludes weight-loss medications, prior authorization usually will not create coverage. Ask whether your employer selected the exclusion, whether a formulary exception is available, and whether another GLP-1 is covered for a medically valid indication.

At a Glance: What Determines Coverage?

Your Situation Likely Coverage Route What Usually Matters
Type 2 diabetes Diabetes medication benefit Type 2 diabetes diagnosis, treatment history, and plan criteria
Obesity or overweight with a related condition Anti-obesity medication benefit BMI, qualifying condition, previous treatment, and lifestyle program
Marketplace insurance Formulary and prior authorization Whether weight-management drugs are included or excluded
Employer insurance Employer plan rules and insurer formulary Summary Plan Description, exclusions, and prior authorization
Medicare Part D in 2026 Part D coverage or Medicare GLP-1 Bridge Eligibility, diagnosis, BMI, qualifying conditions, and drug availability
Medicaid State-specific coverage State Medicaid policy and managed-care formulary

1. Does Your Insurance Plan Cover GLP-1 Drugs for Your Reason for Taking Them?

Start with your plan's formulary, the list of prescription drugs it covers. Search for the exact medication rather than searching for "GLP-1." Review the plan's Summary of Benefits and Coverage as well. If you have employer insurance, check the Summary Plan Description.

HealthCare.gov recommends reviewing the insurer's drug list and coverage documents, then contacting member services before assuming a prescription is covered.

Ask the insurer:

  1. Is Wegovy, Zepbound, Saxenda, Ozempic, Mounjaro, Trulicity, or another specific drug covered?
  2. Is the medication covered for type 2 diabetes, chronic weight management, cardiovascular risk reduction, obstructive sleep apnea, or another indication?
  3. Does the plan exclude anti-obesity or weight-loss medications?
  4. Is prior authorization required?
  5. Is step therapy required, meaning you must try another medication first?
  6. What BMI, diagnosis, laboratory, or treatment-history requirements apply?
  7. What should you expect to pay after the deductible?
  8. Must the prescription come from a particular specialist or pharmacy?

Prior authorization means the health plan must approve a medication before the prescription is filled. It does not guarantee that the plan will pay the claim.

2. Ask for the Medication That Matches the FDA-Approved Indication

Coverage often depends on whether the medication and diagnosis match. Requesting Ozempic or Mounjaro specifically for weight loss can create a coverage problem because insurers may cover those products mainly through their diabetes benefits.

For chronic weight management, the relevant FDA-approved products include Wegovy and Zepbound. The FDA approves Wegovy for long-term weight reduction in adults with obesity or adults who are overweight and have a weight-related condition. Zepbound is approved for chronic weight management in adults with obesity or overweight adults who have at least one weight-related condition.

Wegovy also has an FDA-approved cardiovascular risk-reduction indication for certain adults with established cardiovascular disease who have obesity or are overweight. That indication may matter if your plan covers Wegovy for cardiovascular risk reduction but excludes it for weight loss alone.

Your clinician should submit the diagnosis that accurately describes your medical situation. Do not ask a clinician to submit a false diabetes diagnosis or another inaccurate indication.

3. Have Your Prescriber Prepare a Complete Prior Authorization

A missing record or unanswered plan requirement can delay a request. Ask your clinician's office to submit the prior authorization electronically through the insurer's system and attach the supporting records.

The request may include:

  • Your diagnosis and relevant ICD-10 code
  • Current height, weight, and BMI
  • Weight-related conditions such as hypertension, dyslipidemia, cardiovascular disease, or sleep apnea
  • A diabetes diagnosis and blood-sugar history, when applicable
  • Previous weight-management or diabetes treatments
  • Whether previous medications were ineffective, poorly tolerated, or medically inappropriate
  • Relevant contraindications or safety concerns
  • A treatment plan involving nutrition, physical activity, and follow-up
  • The requested medication, dose, and FDA-approved indication
  • The reason a preferred formulary alternative is unsuitable

Plan rules differ. Published Aetna criteria, for example, can require a patient to try a preferred product before a non-preferred alternative is approved. The criteria may also require documentation of an inadequate response, intolerance, or contraindication. Other plans use different requirements.

Before leaving the clinician's office, ask:

"Has the prior authorization been submitted, and what exact criteria is the insurance company asking you to document?"

4. Understand the Difference Between a Prior-Authorization Denial and a Coverage Exclusion

A prior-authorization denial and a benefit exclusion are different problems. The next step depends on which one appears in the denial notice.

Prior Authorization Denied

This usually means the plan covers the medication in some situations, but the insurer says the submitted information did not meet its criteria. Ask for:

  • The written denial
  • The denial code
  • The specific criterion you did not meet
  • The plan's appeal form
  • The appeal deadline
  • The clinical policy used to make the decision

Your clinician can then submit missing records, correct an error, request a formulary exception, or appeal the medical-necessity decision.

Weight-Loss Medication Excluded

An exclusion means the benefit may not exist under your plan. A medical-necessity appeal may not overcome a clear plan exclusion.

If you have employer insurance, ask the benefits department or plan administrator whether the employer selected the exclusion and whether the plan offers an exception process. The Summary Plan Description explains covered benefits, exclusions, and claim procedures.

The U.S. Department of Labor says many ERISA plans provide at least 180 days to appeal a denied claim. Follow the deadline in your denial notice and plan documents.

5. Appeal the Denial With Evidence

An appeal should respond to the insurer's stated reason for denial. Include:

  1. The denial letter and relevant policy language
  2. Your diagnosis and objective clinical information
  3. Your BMI or diabetes history, when relevant
  4. Previous medications and their outcomes
  5. Documented side effects or contraindications
  6. The reason a preferred alternative will not work
  7. Your clinician's letter of medical necessity
  8. Supporting medical records
  9. A request for a formulary or quantity exception, if appropriate

For Marketplace plans, HealthCare.gov says patients can request an internal appeal and, in eligible cases, an independent external review. A federal external-review request generally must be filed within four months after the final denial. Standard external reviews are generally decided within 45 days, while urgent reviews can be faster.

For Medicare Part D, a coverage determination can address:

  • Prior authorization
  • Formulary exceptions
  • Tiering exceptions
  • Quantity limits
  • Step-therapy requirements

The member, prescriber, or authorized representative can request the determination.

6. Check the Medicare GLP-1 Bridge if You Have Medicare

The Medicare GLP-1 Bridge is scheduled to run through December 31, 2027. It may provide certain GLP-1 drugs to eligible Medicare Part D beneficiaries.

The program currently lists:

  • Foundayo
  • Wegovy injection or tablet
  • Zepbound KwikPen

Eligible patients pay a $50 monthly copayment. That copayment does not count toward the standard Part D deductible or annual out-of-pocket limit.

The Bridge generally requires Medicare drug coverage, age 18 or older, and qualifying BMI and health criteria. Examples include:

  • BMI of 35 or higher
  • BMI of 30 or higher with certain heart failure, uncontrolled hypertension, or stage 3a-or-higher chronic kidney disease
  • BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease

Your provider must prescribe an eligible medication and complete prior authorization when requested. Medicare states that the Bridge is separate from the regular Part D payment process.

If you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease, check your regular Part D plan. Medicare says the plan may cover a GLP-1 for one of those conditions rather than through the Bridge.

7. Check Your State Medicaid Rules Separately

Medicaid GLP-1 coverage varies by state and managed-care plan. Coverage in one state does not establish coverage in another.

CMS provides state-specific prescription-drug resources. State plan amendments can also restrict GLP-1 drugs for weight loss. Pennsylvania's 2026 state plan documents, for example, state that GLP-1 receptor agonists are not covered for weight loss under that plan.

Call your Medicaid plan and ask:

  • Is Wegovy or Zepbound covered?
  • Is weight management a covered indication?
  • Is coverage available only for diabetes or another condition?
  • What BMI and comorbidity requirements apply?
  • Is participation in a lifestyle program required?
  • What are the renewal requirements?

A Phone Script for Your Insurer

Use this wording:

"I am checking whether my plan covers [specific medication] for [specific diagnosis or FDA-approved indication]. Is the medication on my formulary? Does my plan exclude weight-management drugs? What are the prior-authorization, step-therapy, BMI, documentation, and renewal requirements? What will I pay after my deductible?"

Write down the representative's name, the date, the reference number, and the exact policy or formulary document they cite.

Bottom Line

Use the denial language to choose the next step:

  • Missing documentation or an unmet clinical requirement: work with the prescriber on a corrected request or appeal.
  • A formulary problem: ask about a preferred medication or formulary exception.
  • A clear plan exclusion: contact the plan administrator or employer benefits department.
  • An unclear answer: request the written policy, the denial code, and a reference number before submitting anything else.